PLACEMENT AGENCY AGREEMENT between CEL-SCI CORPORATION and THINKEQUITY LLC CEL- SCI CORPORATION PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 18th, 2025 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
This Placement Agency Agreement (the “Agreement”) sets forth the terms upon which ThinkEquity LLC ("ThinkEquity" or the "Placement Agent") shall be engaged by CEL-SCI Corporation, a corporation formed under the laws of the State of Colorado (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of CEL-SCI Corporation, the "Company"), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the "Offering") of up to 4,012,500 shares (the "Shares") of the Company's common stock, par value $0.01 per share (the "Common Stock") and 11,987,500 pre- funded warrants, each to purchase one share of Common Stock at an exercise price of $0.0001 until such time as the Pre-Funded Warrant is exercised in full, subject to adjustment as provided in the Pre-Funded Warrant in the form attached hereto as Exhibit
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 5th, 2025 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • New York
This Placement Agency Agreement (the “Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BriaCell Therapeutics Corp., a corporation formed under the laws of the Province of British Columbia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of BriaCell Therapeutics Corp., the “Company”), to act as the exclusive placement agent in connection with the offering (hereinafter referred to as the “Offering”) of up to 762,500 common shares (the “Shares”) of the Company, with no par value per common share (the “Common Shares”) directly to various investors (each, an “Investor” and, collectively, the “Investors”). The purchase price to the Investors for each Share is $4.00 (the “Share Offering Price”). The Placement Agent may retain other brokers or dealers to act as sub
PLACEMENT AGENCY AGREEMENT between SNOW LAKE RESOURCES LTD. and THINKEQUITY LLCPlacement Agency Agreement • January 24th, 2025 • Snow Lake Resources Ltd. • Miscellaneous metal ores • New York
This Placement Agency Agreement (the "Agreement") sets forth the terms upon which ThinkEquity LLC ("ThinkEquity" or the "Placement Agent") shall be engaged by Snow Lake Resources Ltd., a corporation formed under the laws of the Province of Manitoba, Canada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates Snow Lake Resources Ltd. the "Company"), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the "Offering") of up to 16,000,000 (the "Shares") of the Company's common shares, no par value per share (the "Common Shares") and/or pre-funded warrants, each to purchase one Common Share at an exercise price of $0.001 until such time as the Pre-Funded Warrant is exercised in full, subject to adjustment as provided in the Pre-Funded Warrant in the form attached hereto as Exhibit A (each
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • January 10th, 2025 • XTI Aerospace, Inc. • Services-computer programming services • New York
This Placement Agency Agreement the (this “Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by XTI Aerospace, Inc., a Nevada corporation (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of XTI Aerospace, Inc., the “Company”), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the “Offering”) of up to 363,636,364 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), and/or pre-funded common stock purchase warrants, each to purchase one share of Common Stock (the “Pre-funded Warrants” and the shares of Common Stock underlying the Pre-funded Warrants, the “Warrant Shares,” and the Shares, the Pre-funded Warrants and the Warrant Shares, the “Securities”) directly to va
PLACEMENT AGENCY AGREEMENT between SNOW LAKE RESOURCES LTD. and THINKEQUITY LLCPlacement Agency Agreement • December 30th, 2024 • Snow Lake Resources Ltd. • Miscellaneous metal ores • New York
This Placement Agency Agreement (the "Agreement") sets forth the terms upon which ThinkEquity LLC ("ThinkEquity" or the "Placement Agent") shall be engaged by Snow Lake Resources Ltd., a corporation formed under the laws of the Province of Manitoba, Canada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates Snow Lake Resources Ltd. the "Company"), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the "Offering") of up to 18,750,000 (the "Shares") of the Company's common shares, no par value per share (the "Common Shares") and/or pre-funded warrants, each to purchase one Common Share at an exercise price of $0.001 until such time as the Pre-Funded Warrant is exercised in full, subject to adjustment as provided in the Pre-Funded Warrant in the form attached hereto as Exhibit A (each
PLACEMENT AGENCY AGREEMENT between SNOW LAKE RESOURCES LTD. and THINKEQUITY LLCPlacement Agency Agreement • December 20th, 2024 • Snow Lake Resources Ltd. • Miscellaneous metal ores • New York
This Placement Agency Agreement (the "Agreement") sets forth the terms upon which ThinkEquity LLC ("ThinkEquity" or the "Placement Agent") shall be engaged by Snow Lake Resources Ltd., a corporation formed under the laws of the Province of Manitoba, Canada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates Snow Lake Resources Ltd. the "Company"), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the "Offering") of up to 15,750,000 (the "Shares") of the Company's common shares, no par value per share (the "Common Shares") and/or pre-funded warrants, each to purchase one Common Share at an exercise price of $0.001 until such time as the Pre-Funded Warrant is exercised in full, subject to adjustment as provided in the Pre-Funded Warrant in the form attached hereto as Exhibit A (each
PLACEMENT AGENCY AGREEMENT between KWESST MICRO SYSTEMS INC. and THINKEQUITY LLCPlacement Agency Agreement • October 28th, 2024 • KWESST Micro Systems Inc. • Services-prepackaged software • New York
This Placement Agency Agreement (the "Agreement") sets forth the terms upon which ThinkEquity LLC ("ThinkEquity" or the "Placement Agent") shall be engaged by KWESST Micro Systems Inc., a corporation formed under the laws of British Columbia, Canada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates KWESST Micro Systems Inc. the "Company"), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the "Offering") of up to [__] (the "Shares") of the Company's common shares, no par value per share (the "Common Shares") and up to [ ] pre-funded warrants, each to purchase one Common Share at an exercise price of $0.001 until such time as the Pre-Funded Warrant is exercised in full, subject to adjustment as provided in the Pre-Funded Warrant in the form attached hereto as Exhibit A (each a "Pr
ContractPlacement Agency Agreement • October 24th, 2024 • Biovie Inc. • Pharmaceutical preparations • New York
CERTAIN PERSONALLY IDENTIFIABLE INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO ITEM 601(A)(6) OF REGULATION S-K. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.
PLACEMENT AGENCY AGREEMENT between BRIACELL THERAPEUTICS CORP. and THINKEQUITY LLC BRIACELL THERAPEUTICS CORP. PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • October 2nd, 2024 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • New York
This Placement Agency Agreement (the “Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BriaCell Therapeutics Corp., a corporation formed under the laws of the Province of British Columbia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of BriaCell Therapeutics Corp., the “Company”), to act as the exclusive placement agent in connection with the offering (hereinafter referred to as the “Offering”) of up to 5,128,500 units (the “Units”) of the Company, consisting of 5,128,500 Class A Units (as defined below) and 0 Class B Units (as defined below), each consisting of either: (A) one common share, with no par value per common share (each, a “Common Share”) and one warrant (each, a “Warrant”) to purchase one Common Share at an exercise price of $0.85 for a peri
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 24th, 2024 • Biovie Inc. • Pharmaceutical preparations • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BioVie Inc., a Nevada corporation (the “Company”), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the “Offering”) of up to 1,960,800 shares (the “Shares”) of the Company’s class A common stock, $0.0001 par value per share (the “Common Stock”), and/or pre-funded common stock purchase warrants to purchase one share of Common Stock (the “Pre-Funded Warrants”), together with common stock purchase warrants to purchase up to 1,960,800 shares of Common Stock (the “Warrants,” the shares of Common Stock underlying the Pre-Funded Warrants and Warrants, the “Warrant Shares”, and the Shares, the Pre-Funded Warrants, Warrants and the Warrant Shares, the “Securities”) directly to various investors (each, an “Investor” and, collectively, the “Investors”). The purchase price to t
PLACEMENT AGENCY AGREEMENT between BRIACELL THERAPEUTICS CORP. and THINKEQUITY LLC BRIACELL THERAPEUTICS CORP. PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 12th, 2024 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • New York
This Placement Agency Agreement (the “Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BriaCell Therapeutics Corp., a corporation formed under the laws of the Province of British Columbia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of BriaCell Therapeutics Corp., the “Company”), to act as the exclusive placement agent in connection with the offering (hereinafter referred to as the “Offering”) of up to 12,325,000 common shares (the “Shares”) of the Company, with no par value per common share (the “Common Shares”) and 0 pre-funded warrants, each to purchase one Common Share at an exercise price of $0.001 until such time as the Pre-Funded Warrant is exercised in full, subject to adjustment as provided in the form attached hereto as Exhibit D (each a “Pre-
CERTAIN PERSONALLY IDENTIFIABLE INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO ITEM 601(A)(6) OF REGULATION S-K. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 4th, 2024 • Biovie Inc. • Pharmaceutical preparations • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BioVie Inc., a Nevada corporation (the “Company”), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the “Offering”) of up to 21,000,000 shares (the “Shares”) of the Company’s class A common stock, $0.0001 par value per share (the “Common Stock”), and/or pre-funded common stock purchase warrants to purchase one share of Common Stock (the “Pre-Funded Warrants”), together with common stock purchase warrants to purchase up to 10,500,000 shares of Common Stock (the “Warrants,” the shares of Common Stock underlying the Pre-Funded Warrants and Warrants, the “Warrant Shares”, and the Shares, the Pre-Funded Warrants, Warrants and the Warrant Shares, the “Securities”) directly to various investors (each, an “Investor” and, collectively, the “Investors”). The purchase price to
PLACEMENT AGENCY AGREEMENT January 13, 2021Placement Agency Agreement • January 15th, 2021 • Nano Dimension Ltd. • Printed circuit boards • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Nano Dimension Ltd., a company organized under the laws of the State of Israel (the “Company”), to act as the exclusive Placement Agent in connection with the registered direct offering (hereinafter referred to as the “Offering”) of American Depositary Shares (“ADS”), each ADS representing one (1) ordinary share, par value NIS 5.00 per share (the “Ordinary Shares” and, together with the ADSs, the “Public Securities”), of the Company deposited with the Depositary (as defined below), as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement to be entered into in connection with the Offering, in the form of Exhibit A (collectively, the “Securities Purchase Agreement”)
PLACEMENT AGENCY AGREEMENT December 27, 2020Placement Agency Agreement • December 28th, 2020 • Nano Dimension Ltd. • Printed circuit boards • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Nano Dimension Ltd., a company organized under the laws of the State of Israel (the “Company”), to act as the exclusive Placement Agent in connection with the registered direct offering (hereinafter referred to as the “Offering”) of American Depositary Shares (“ADS”), each ADS representing one (1) ordinary share, par value NIS 5.00 per share (the “Ordinary Shares” and, together with the ADSs, the “Public Securities”), of the Company deposited with the Depositary (as defined below), as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement to be entered into in connection with the Offering, in the form of Exhibit A (collectively, the “Securities Purchase Agreement”)
PLACEMENT AGENCY AGREEMENT December 6, 2020Placement Agency Agreement • December 7th, 2020 • Nano Dimension Ltd. • Printed circuit boards • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Nano Dimension Ltd., a company organized under the laws of the State of Israel (the “Company”), to act as the exclusive Placement Agent in connection with the registered direct offering (hereinafter referred to as the “Offering”) of American Depositary Shares (“ADS”), each ADS representing one (1) ordinary share, par value NIS 5.00 per share (the “Ordinary Shares” and, together with the ADSs, the “Public Securities”), of the Company deposited with the Depositary (as defined below), as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement to be entered into in connection with the Offering, in the form of Exhibit A (collectively, the “Securities Purchase Agreement”)
PLACEMENT AGENCY AGREEMENT November 29, 2020Placement Agency Agreement • November 30th, 2020 • Nano Dimension Ltd. • Printed circuit boards • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Nano Dimension Ltd., a company organized under the laws of the State of Israel (the “Company”), to act as the exclusive Placement Agent in connection with the registered direct offering (hereinafter referred to as the “Offering”) of American Depositary Shares (“ADS”), each ADS representing one (1) ordinary share, par value NIS 5.00 per share (the “Ordinary Shares” and, together with the ADSs, the “Public Securities”), of the Company deposited with Bank Hapoalim or Bank Leumi, as custodian for the Depositary (as defined below) in Tel Aviv of the Company, as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement to be entered into in connection with the Offering, in
PLACEMENT AGENCY AGREEMENT November 19, 2020Placement Agency Agreement • November 23rd, 2020 • Nano Dimension Ltd. • Printed circuit boards • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Nano Dimension Ltd., a company organized under the laws of the State of Israel (the “Company”), to act as the exclusive Placement Agent in connection with the registered direct offering (hereinafter referred to as the “Offering”) of American Depositary Shares (“ADS”), each ADS representing one (1) ordinary share, par value NIS 5.00 per share (the “Ordinary Shares” and, together with the ADSs, the “Public Securities”), of the Company deposited with Bank Hapoalim or Bank Leumi, as custodian for the Depositary (as defined below) in Tel Aviv of the Company, as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement to be entered into in connection with the Offering, in
PLACEMENT AGENCY AGREEMENT October 26, 2020Placement Agency Agreement • October 27th, 2020 • Nano Dimension Ltd. • Printed circuit boards • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Nano Dimension Ltd., a company organized under the laws of the State of Israel (the “Company”), to act as the exclusive Placement Agent in connection with the registered direct offering (hereinafter referred to as the “Offering”) of American Depositary Shares (“ADS”), each ADS representing one (1) ordinary share, par value NIS 5.00 per share (the “Ordinary Shares” and, together with the ADSs, the “Public Securities”), of the Company deposited with Bank Hapoalim or Bank Leumi, as custodian for the Depositary (as defined below) in Tel Aviv of the Company, as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement to be entered into in connection with the Offering, in
PLACEMENT AGENCY AGREEMENT September 30, 2020Placement Agency Agreement • October 2nd, 2020 • Nano Dimension Ltd. • Printed circuit boards • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Nano Dimension Ltd., a company organized under the laws of the State of Israel (the “Company”), to act as the exclusive Placement Agent in connection with the registered direct offering (hereinafter referred to as the “Offering”) of American Depositary Shares (“ADS”), each ADS representing one (1) ordinary share, par value NIS 5.00 per share (the “Ordinary Shares” and, together with the ADSs, the “Public Securities”), of the Company deposited with Bank Hapoalim or Bank Leumi, as custodian for the Depositary (as defined below) in Tel Aviv of the Company, as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement to be entered into in connection with the Offering, in
PLACEMENT AGENCY AGREEMENT between BRIACELL THERAPEUTICS CORP. and THINKEQUITY A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC. as Placement Agent BRIACELL THERAPEUTICS CORP.Placement Agency Agreement • May 27th, 2020 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • New York
The undersigned, BriaCell Therapeutics Corp., a corporation formed under the laws of the Province of British Columbia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of BriaCell Therapeutics Corp. (the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity, a division of Fordham Financial Management, Inc., (hereinafter referred to as “you” (including its correlatives) or the “Placement Agent”) as follows:
PLACEMENT AGENCY AGREEMENT May 20, 2020Placement Agency Agreement • May 20th, 2020 • Nano Dimension Ltd. • Printed circuit boards • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Nano Dimension Ltd., a company organized under the laws of the State of Israel (the “Company”), to act as the exclusive Placement Agent in connection with the registered direct offering (hereinafter referred to as the “Offering”) of American Depositary Shares (“ADS”), each ADS representing fifty (50) ordinary shares, par value NIS 0.1 per share (the “Ordinary Shares” and, together with the ADSs, the “Public Securities”), of the Company deposited with Bank Hapoalim or Bank Leumi, as custodian for the Depositary (as defined below) in Tel Aviv of the Company, as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement to be entered into in connection with the Offering,
PLACEMENT AGENCY AGREEMENT between BIOVIE INC. and THINKEQUITY A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC. as Placement Agent BIOVIE INC.Placement Agency Agreement • March 11th, 2020 • Biovie Inc. • Pharmaceutical preparations • New York
The undersigned, BioVie Inc., a corporation formed under the laws of the State of Nevada (the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity, a division of Fordham Financial Management, Inc., (hereinafter referred to as “you” (including its correlatives) or the “Placement Agent”) as follows:
PLACEMENT AGENCY AGREEMENT June 17, 2019Placement Agency Agreement • June 17th, 2019 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Introductory. This Placement Agency Agreement the (“Agreement”) sets forth the terms upon which ThinkEquity, a division of Fordham Financial Management, Inc., (“ThinkEquity” or the “Placement Agent”) shall be engaged by Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), to act as the exclusive Placement Agent in connection with the offering (hereinafter referred to as the “Offering”) of securities of the Company, as more fully described below. Capitalized terms used but not defined in this Agreement shall have the meaning ascribed to them in the Securities Purchase Agreement (defined below).
Matinas biopharma holdings, Inc. (a Delaware corporation) 8,000 Shares of Series B Convertible Preferred Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • June 19th, 2018 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New York
Matinas BioPharma Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the purchasers (each, a “Purchaser” and, collectively, the “Purchasers”), pursuant to the terms and conditions of this Placement Agent Agreement (this “Agreement”) up to an aggregate of 8,000 shares (the “Shares”) of Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”). The offering and sale of the Shares of Series B Preferred Stock is hereinafter referred to as the “Offering.” The Company hereby confirms its agreement with ThinkEquity, a division of Fordham Financial Management, Inc. (the “Placement Agent”) to act as Placement Agent in accordance with the terms and conditions hereof.
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • October 31st, 2016 • Poet Technologies Inc. • Semiconductors & related devices • New York
The undersigned, Poet Technologies Inc., a company incorporated under the laws of the Province of Ontario, Canada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Poet Technologies Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several placement agents (such placement agents, including the Representative (as defined below), the “Placement Agents” and each a “Placement Agent”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Placement Agents (the “Representative”) and Cormark Securities Inc. (as lead placement agent in Canada) on the terms and conditions set forth herein.
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 9th, 2015 • Ominto, Inc. • Services-business services, nec • New York
Introduction. Subject to the terms and conditions herein (this “Agreement”), Ominto, Inc., a Nevada corporation (the “Company”), hereby agrees to sell up to an aggregate of $[__] of registered securities of the Company, including, but not limited to, shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), together with warrants to purchase Common Stock at an exercise price of $__ per share (the “Warrants” and the shares of Common Stock underlying the Warrants, the “Warrant Shares”), (the Shares, Warrants and Warrant Shares, collectively, the “Securities”) directly to various investors (each, an “Investor” and, collectively, the “Investors”) through Chardan Capital Markets, LLC, as placement agent (the “Placement Agent”). The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Offering (as defined below) whose fees and expenses shall be borne exclusively by the Pla
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 18th, 2013 • Z Trim Holdings, Inc • Grain mill products • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 4th, 2013 • Z Trim Holdings, Inc • Grain mill products • New York
PLACEMENT AGENCY AGREEMENT July 21, 2013Placement Agency Agreement • July 25th, 2013 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • New York
PLACEMENT AGENCY AGREEMENT July 21, 2013Placement Agency Agreement • July 25th, 2013 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 17th, 2013 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • June 29th, 2012 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances) • New York